2 results about "CADA compound" patented technology

The disclosure relates to malonic acid and derivatives thereof of formula (I) below for use as an agent for promoting metallothionein biosynthesis in a patient:X and Y are each independently selected from —O−M+, —OR1, and —NR2R3, M+ is selected from monovalent or polyvalent metal cations, and R1, R2 and R3 are each independently selected from hydrogen and saturated or unsaturated, linear, branched or cyclic hydrocarbon radicals having from 1 to 25 carbon atoms, and one or more carbon atoms are optionally substituted for O or N, R2 and R3 being optionally connected to form a heterocyclic hydrocarbon radical together with the nitrogen atom. The disclosure also relates to a pharmaceutical composition containing a compound of formula (I).

A layered semiconductor device comprising a mixed ligand compound, the mixed ligand compound comprising: a cyclophosphazene core moiety, a first ligand moiety, and a second ligand moiety. The first ligand moiety and the second ligand moiety are each bonded to the core moiety. A composition comprising a plurality of compounds, each compound thereof comprises a cyclophosphazene core moiety, and at least one ligand moiety bonded to the cyclophosphazene core moiety; the plurality of compounds comprises at least one ligand moiety in common.